Corpus Intelligence IC Memo — MEMORIAL HOSPITAL 2026-04-26 15:53 UTC
IC Memo — MEMORIAL HOSPITAL
Investment Committee Memorandum | GA | 80 beds | Grade D | EBITDA uplift $3.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEMORIAL HOSPITAL

CCN 110132 | DECATUR, GA | 80 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MEMORIAL HOSPITAL is a 80-bed under-performing / distressed in DECATUR, GA with $46.0M in net patient revenue and a -13.6% operating margin. The hospital serves a payer mix of 26.2% Medicare, 5.7% Medicaid, and 68.1% commercial.

Thesis: Turnaround. Our ML models identify $3.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.6% to -6.3% (+736bps).

Net Revenue HCRIS$46.0M
Current EBITDA COMPUTED$-6.3M
Operating Margin COMPUTED-13.6%
Occupancy HCRIS16.9%
Revenue / Bed COMPUTED$575K
Net-to-Gross HCRIS32.6%
Distress Probability ML57.2%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
68
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of -13.6% places it below the state median. Among 68 size-comparable peers (40-160 beds), the median margin is -0.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 68 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEMORIAL HOSPITAL (Target)GA80$46.0M-13.6%
TANNER MEDICAL CENTER-VILLA RIGA58$289.8M33.3%
PAULDING MEDICAL CENTERGA112$288.5M9.0%
EMORY JOHNS CREEK HOSPITALGA154$269.1M3.5%
SHEPHERD CENTERGA130$254.9M-20.8%
PIEDMONT ROCKDALE HOSPITALGA141$217.4M-4.1%
DOUGLAS HOSPITALGA112$217.2M-0.8%
NORTHSIDE HOSPITAL - DULUTHGA87$193.2M-3.1%
ADVENTHEALTH GORDONGA69$188.5M-3.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$965K+210bp18mo
Cost to Collect4.5%2.5%$919K+200bp12mo
Denial Rate Reduction12.0%6.5%$910K+198bp12mo
A/R Days Reduction5200.0%3800.0%$559K+122bp9mo
Clean Claim Rate88.0%96.0%$29K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$965K
Cost to Collect
$919K
Denial Rate Reduction
$910K
A/R Days Reduction
$559K
Clean Claim Rate
$29K
Total EBITDA Uplift$3.4M
Current EBITDA$-6.3M
+ RCM Uplift+$3.4M
Pro Forma EBITDA$-2.9M
Current Margin-13.6%
Pro Forma Margin-6.3%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.6M$-7.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.6M$-11.4M0.00x-100.0%
Bull Case9.0x11.0x$-8.7M$-3.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.7M$-6.2M0.00x-100.0%
Bear Case11.0x10.0x$-10.6M$-21.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.6M$-26.9M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 16.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 68 hospitals with 40-160 beds
  • Same-state prioritization (n=69)
  • Comp margins: P25=-11.9% / P50=-0.3% / P75=8.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.